Glenmark Pharmaceuticals has received final USFDA approval for Acyclovir Ointment used for treatment of herpes virus. The drug will be made available in USP, 5 per cent, the generic version of Zovirax Ointment, 5 per cent, of Valeant International Bermuda. According to IMS Health sales data for the 12 months to June 2017, Zovirax Ointment achieved annual sales of approximately USD 110.3 million
Company Profile : Glenmark Pharma Ltd
Leave a Reply